Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial - Bhatt - 2021 - European Journal of Heart Failure - Wiley Online Library
Neprilysin: Indications, Expectations, and Challenges | Revista Española de Cardiología
Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review - International Journal of Cardiology
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure | Circulation
![PDF] Critical Questions about PARADIGM-HF and the Future. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/918ced0a75a7d84e5e8997682bb61d92ebedf17a/4-Figure2-1.png "PDF] Critical Questions about PARADIGM-HF and the Future. | Semantic Scholar")
PDF] Critical Questions about PARADIGM-HF and the Future. | Semantic Scholar
Historical timeline of breakthrough clinical trials for heart failure... | Download Scientific Diagram
Frontiers | Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum
Emerging Mechanisms in the Management of Heart Failure With Reduced Ejection Fraction
Clinical Trial and Biomarker Data | ENTRESTO® (sacubitril/valsartan) | HCP
PARADISE MI Trial: Is Sacubitril/valsartan (Entresto) useful in patients with acute MI? – Visualmed
Clinical Trial and Biomarker Data | ENTRESTO® (sacubitril/valsartan) | HCP
Use of Sacubitril/Valsartan in Heart Failure
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis | JACC: Heart Failure
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM
KoreaMed Synapse
PARADIGM-HF and PARAGON-HF: Redefining HFrEF and HFpEF - PACE-CME
Critical Questions about PARADIGM-HF and the Future
Industry Sponsored Trials and Entresto in CHF - REBEL EM - Emergency Medicine Blog
Entresto Use in Heart Failure w Preserved Function – The Early Career Voice
PARADIGM-HF: A Concise Summary with Journal Club Questions - YouTube
Promising New Therapies in Heart Failure: Ivabradine and the Neprilysin Inhibitors | USC Journal
Entrestro for HFrEF: Are there any controversies?
Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V. - ppt video online download
Trial Scorecard: PARADIGM-HF
